In late 2014, Medicines Australia adopted a new code of conduct, Edition 18, which applies to pharmaceutical companies and took effect in January of 2015.
Among many subtle changes to the ethical code, Australia completely overhauled its transparency reporting requirements.
To read the article by By Joyce Crawford
